Hartford Funds Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Buy |
1,754
+394
| +29% | +$176K | 0.07% | 66 |
|
|
2025
Q1 | $659K | Buy |
1,360
+239
| +21% | +$116K | 0.06% | 75 |
|
|
2024
Q4 | $451K | Buy |
1,121
+46
| +4% | +$18.5K | 0.04% | 89 |
|
|
2024
Q3 | $500K | Buy |
1,075
+42
| +4% | +$19.5K | 0.05% | 81 |
|
|
2024
Q2 | $484K | Buy |
1,033
+58
| +6% | +$27.2K | 0.05% | 77 |
|
|
2024
Q1 | $407K | Buy |
975
+85
| +10% | +$35.5K | 0.04% | 79 |
|
|
2023
Q4 | $362K | Buy |
890
+64
| +8% | +$26K | 0.04% | 76 |
|
|
2023
Q3 | $287K | Buy |
826
+53
| +7% | +$18.4K | 0.03% | 74 |
|
|
2023
Q2 | $272K | Buy |
773
+107
| +16% | +$37.7K | 0.03% | 80 |
|
|
2023
Q1 | $210K | Buy |
+666
| New | +$210K | 0.02% | 84 |
|